Patients with desmoplastic melanoma, a rare subtype of melanoma may be more responsive to anti-PD-1/PD-L1 therapies. Desmoplastic melanoma is commonly from Latest Cancer News http://ift.tt/2mjef4h
No comments
Thanks for comment via will connect you within 24 hours.